Roles of CD5+, CD19+, CD41a+, CD55+ and CD59+ in Chronic Immune Thrombocytopenic Purpura (ITP) (original) (raw)
A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura
ana ani
Annals of Hematology, 2008
View PDFchevron_right
Value of Pre- and Post-Treatment Platelet Indices in Patients with Immune Thrombocytopenic Purpura
noha emam
Journal of Biosciences and Medicines, 2018
View PDFchevron_right
Involvement of Autoimmune Diseases in the Pathogenesis of Chronic Immune Thrombocytopenic Purpura
Codruţa Bădescu, Manuela Ciocoiu
Journal of Biomedical Science and Engineering, 2015
View PDFchevron_right
Immune Thrombocytopenic Purpura in Review
Nashwa Alzahrani
2021
View PDFchevron_right
Functional properties of lymphocytes in idiopathic thrombocytopenic purpura
John Mascarenhas
Human Immunology, 2001
View PDFchevron_right
Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA
Stefan Jacobsson
European Journal of Haematology, 2009
View PDFchevron_right
Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon [see comments]
Dipnarine Maharaj
Blood, 1989
View PDFchevron_right
Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance
Penny Ballem
Journal of Clinical Investigation, 1987
View PDFchevron_right
Platelet Indices - Can They Assess Bleeding Risk in Patients of Immune Thrombocytopenic Purpura? - a Prospective Study
anjali tewari
IJAR - Indian Journal of Applied Research, 2021
View PDFchevron_right
Significance of Immature Platelet Fraction in Diagnosed Patients of the Immune Thrombocytopenic Purpura
Maliha Bukhari
Pakistan Armed Forces Medical Journal
View PDFchevron_right
Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ
Henry Pieters
Blood, 1986
View PDFchevron_right
Long-term management of chronic immune thrombocytopenic purpura in adults
Javier Palau, Isidro Jarque
International Journal of General Medicine, 2010
View PDFchevron_right
Platelet turnover and kinetics in immune thrombocytopenic purpura: Results with autologus 111-In-labeled and homologous 51-Cr-labeled platelets differ
Philip Badenhorst
Blood
View PDFchevron_right
Correlations among age, cytokines, lymphocyte subtypes, and platelet counts in autoimmune thrombocytopenic purpura
Srdana Ñ Culić
Pediatric Blood & Cancer, 2006
View PDFchevron_right
Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura
Mahwish Shaikh
Pakistan Journal of Medical Sciences, 2016
View PDFchevron_right
Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia
Nora Goette
Scientific Reports
View PDFchevron_right
Platelet Autoantibodies in Immune Thrombocytopenic Purpura
M. Ertem
Transfusion Science, 1998
View PDFchevron_right
IMMUNE THROMBOCYTOPENIC PURPURA: A HAEMATOLOGICAL DISORDER Review Article
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)
International Journal of Pharmacy and Pharmaceutical Sciences, 2024
View PDFchevron_right
Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets
Penny Ballem
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1989
View PDFchevron_right
The efficacy and safety of B‐cell depletion with anti‐CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
james bussel
British Journal of Haematology, 2004
View PDFchevron_right
111In-platelets dynamic study in chronic immune thrombocytopenic purpura
Ivo V Elezovic
PubMed, 2002
View PDFchevron_right
Recent Advances in the Treatment of Chronic Refractory Immune Thrombocytopenic Purpura
Kiarash Kojouri
International Journal of Hematology, 2005
View PDFchevron_right
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)
james bussel
Blood, 2007
View PDFchevron_right
Screening for Platelet Antibodies in Adult Idiopathic Thrombocytopenic Purpura: A Comparative Study Using Solid Phase Red Cell Adherence Assay and Flow Cytometry
Jeong-Shi Lin
Journal of the Chinese Medical Association, 2006
View PDFchevron_right
Flow cytometric analysis of anti-platelet antibodies in idiopathic thrombocytopenic purpura
Roberto Reverberi
Haematologica
View PDFchevron_right
Prevalence of Autoantibodies Related to Some Autoimmune Disorders in Patients With Chronic Idiopathic Thrombocytopenic Purpura
Ramazan Esen
Clinical and Applied Thrombosis/Hemostasis, 2010
View PDFchevron_right
Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response
Maria Theodoropoulou
Blood, 2004
View PDFchevron_right
Predictors of chronic idiopathic thrombocytopenic purpura
M. Elalfy
Pediatric Blood & Cancer, 2010
View PDFchevron_right
Reverse Angle: Immunological Evaluation of Patients with Idiopathic Thrombocytopenic Purpura: A Retrospective Cohort Study
fatih çölkesen
Asthma Allergy Immunology
View PDFchevron_right
Predictive Value of Risk Factors for Chronic Idiopathic Thrombocytopenic Purpura in Patients with Acute Type of Disease
Mohammad Faranoush
Open Access Macedonian Journal of Medical Sciences, 2020
View PDFchevron_right
Comparison of conventional dose steroid treatment and high dose steroid treatment as run-in regime for splenectomy in immune thrombocytopenic purpura (ITP)
Oktay Bilgir
Transfusion and Apheresis Science, 2011
View PDFchevron_right
Importance Of Immature Platelet Fraction As Predictor Of Immune Thrombocytopenia Purpura
Samina Naz Mukry
Pakistan Journal of Medical Sciences, 1969
View PDFchevron_right